Table 3.
Incidence rate ratios for cancer in association with markers of traffic at residence at the time of enrolment into the cohort between 1993 and 1997
| Cancer site (ICD-7) | Incidence rate ratioa (95% CI) | |||
|---|---|---|---|---|
| Major street within 50 m (yes versus no) |
Per 104 vehicle km/day within 200 m |
|||
| Crude | Adjustedb | Crude | Adjustedb | |
| Buccal cavity and pharynx (140-148) | 0.92 (0.45;1.90) | 0.85 (0.41;1.77) | 0.98 (0.68;1.41) | 0.87 (0.59;1.29) |
| Esophagus (150) | 1.59 (0.82;3.10) | 1.38 (0.71;2.68) | 1.20 (0.84;1.72) | 1.07 (0.73;1.58) |
| Stomach (151) | 1.01 (0.46;2.19) | 0.92 (0.42;1.98) | 1.08 (0.74;1.58) | 1.00 (0.70;1.48) |
| Colon (153) | 1.13 (0.82;1.55) | 0.89 (0.41;1.95) | 1.04 (0.88;1.23) | 0.99 (0.66;1.47) |
| Rectum (154) | 1.03 (0.67;1.58) | 1.00 (0.64;1.56) | 0.94 (0.75;1.18) | 0.92 (0.72;1.16) |
| Liver (155.0) | 1.58 (0.74;3.34) | 1.40 (0.66;2.98) | 1.55 (1.09;2.20) | 1.45 (1.00;2.09) |
| Pancreas (157) | 0.92 (0.47;1.82) | 0.79 (0.38;1.63) | 0.78 (0.53;1.14) | 0.73 (0.49;1.09) |
| Larynx (161) | 1.24 (0.56;2.72) | 1.03 (0.47;2.27) | 1.28 (0.88;1.87) | 1.13 (0.75;1.70) |
| Breast (170) | 1.11 (0.90;1.38) | 0.98 (0.78;1.22) | 1.08 (0.98;1.21) | 0.98 (0.88;1.10) |
| Cervix (171) | 4.67 (2.29;9.52) | 4.36 (2.12;8.95) | 1.88 (1.27;2.79) | 1.70 (1.12;2.58) |
| Uteri (172) | 1.15 (0.70;1.90) | 0.96 (0.55;1.66) | 1.19 (0.94;1.52) | 1.15 (0.90;1.49) |
| Ovary (175) | 0.50 (0.20;1.23) | 0.49 (0.20;1.19) | 0.88 (0.61;1.26) | 0.80 (0.54;1.17) |
| Prostate (177) | 0.88 (0.67;1.17) | 0.91 (0.69;1.21) | 0.91 (0.79;1.05) | 0.96 (0.83;1.11) |
| Kidney (180) | 1.29 (0.71;2.35) | 0.90 (0.44;1.87) | 1.10 (0.80;1.51) | 1.10 (0.78;1.54) |
| Bladder (181) | 1.06 (0.68;1.66) | 0.94 (0.60;1.48) | 1.20 (0.97;1.47) | 1.09 (0.87;1.35) |
| Melanoma (190) | 0.69 (0.40;1.19) | 0.65 (0.37;1.14) | 0.83 (0.64;1.08) | 0.83 (0.64;1.09) |
| Brain (193) | 1.89 (1.07;3.34) | 1.89 (1.07;3.36) | 1.27 (0.93;1.75) | 1.27 (0.93;1.75) |
| Non-Hodgkin lymphoma (200, 202) | 0.91 (0.54;1.51) | 0.90 (0.54;1.51) | 1.06 (0.83;1.35) | 1.06 (0.83;1.35) |
| Myeloma (203) | 1.06 (0.46;2.45) | 1.06 (0.46;2.45) | 0.78 (0.48;1.29) | 0.78 (0.48;1.29) |
| Leukemia (204) | 0.79 (0.39;1.62) | 0.81 (0.39;1.66) | 0.73 (0.50;1.09) | 0.75 (0.51;1.11) |
a Based on same data as the analyses shown in Table 2
b Adjustments identical to those in Table 2